NLRP3 and Cerebral ischemia: Therefore, the above results suggest that the neuroprotective effect of EA on cerebral ischemia/reperfusion injury reduces the pyroptosis of nerve cells by inhibiting the expression of NLRP3 and caspase-1, thereby reducing the release of inflammatory factors, such as IL-1β, so as to reduce the inflammatory response.